The Relationship between Aggregation and Toxicity of Polyglutamine-Containing Ataxin-3 in the Intracellular Environment of Escherichia coli

Several neurodegenerative diseases are triggered by proteins containing a polyglutamine (polyQ) stretch expanded beyond a critical threshold. Among these, ataxin-3 (AT3) is the causative agent of spinocerebellar ataxia type-3. We expressed three authentic AT3 variants in Escherichia coli: one normal (AT3-Q24), one expanded (AT3-Q55) and one truncated immediately upstream of the polyQ (AT3-291Δ). Then, based on growth rate reduction, we quantified protein toxicity. We show that AT3-Q55 and -291Δ strongly reduced the growth rate in the early stages (2–4 h), unlike AT3-Q24. This correlated well with the appearance of soluble cytosolic oligomers, but not with the amount of insoluble protein in inclusion bodies (IBs). The impact of AT3-291Δ on cell growth suggests an intrinsic toxicity of the AT3 fragment. Besides the typical Fourier Transform Infrared Spectroscopy (FTIR) signal for intermolecular β-sheets, the expanded form displayed an additional infrared signature, which was assigned to glutamine side-chain hydrogen bonding and associated with SDS-insoluble fibrils. The elongation of the latter was monitored by Atomic Force Microscopy (AFM). This mirrors the well-known in vitro two-step aggregation pattern of expanded AT3. We also demonstrated that final aggregates of strains expressing expanded or truncated AT3 play a protective role against toxicity. Furthermore, our findings suggest that the mechanisms of toxicity are evolutionarily conserved.

[1]  Christopher M. Dobson,et al.  Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.

[2]  S. Doglia,et al.  The role of the central flexible region on the aggregation and conformational properties of human ataxin‐3 , 2012, The FEBS journal.

[3]  M. Engelhard,et al.  Structural characterization of polyglutamine fibrils by solid-state NMR spectroscopy. , 2011, Journal of molecular biology.

[4]  S. Doglia,et al.  Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology , 2011, The FEBS journal.

[5]  H. Arnold,et al.  N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation. , 2011, Brain : a journal of neurology.

[6]  Antonio Villaverde,et al.  Biological role of bacterial inclusion bodies: a model for amyloid aggregation , 2011, The FEBS journal.

[7]  Alessandra Gliozzi,et al.  A Major Role for Side-Chain Polyglutamine Hydrogen Bonding in Irreversible Ataxin-3 Aggregation , 2011, PloS one.

[8]  E. Giralt,et al.  Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties. , 2011, Journal of the American Chemical Society.

[9]  U. Fink,et al.  Bacterial Inclusion Bodies of Alzheimer's Disease β‐Amyloid Peptides Can Be Employed To Study Native‐Like Aggregation Intermediate States , 2011, Chembiochem : a European journal of chemical biology.

[10]  Masino Laura,et al.  Functional interactions as a survival strategy against abnormal aggregation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  E. Snapp,et al.  Formation and Toxicity of Soluble Polyglutamine Oligomers in Living Cells , 2010, PloS one.

[12]  Bernd Bukau,et al.  Cellular strategies for controlling protein aggregation , 2010, Nature Reviews Molecular Cell Biology.

[13]  Gengfu Xiao,et al.  Macromolecular crowding converts the human recombinant PrPc to the soluble neurotoxic β‐oligomers , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Steven Finkbeiner,et al.  Quantitative Relationships between Huntingtin Levels, Polyglutamine Length, Inclusion Body Formation, and Neuronal Death Provide Novel Insight into Huntington's Disease Molecular Pathogenesis , 2010, The Journal of Neuroscience.

[15]  Niccolò Taddei,et al.  Low-level expression of a folding-incompetent protein in Escherichia coli: search for the molecular determinants of protein aggregation in vivo. , 2010, Journal of molecular biology.

[16]  Andrew F Hill,et al.  Tracking Mutant Huntingtin Aggregation Kinetics in Cells Reveals Three Major Populations That Include an Invariant Oligomer Pool* , 2010, The Journal of Biological Chemistry.

[17]  Fabrizio Chiti,et al.  A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.

[18]  S. Radford,et al.  Fibril Fragmentation Enhances Amyloid Cytotoxicity*♦ , 2009, The Journal of Biological Chemistry.

[19]  C. Glabe,et al.  Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction , 2009, Neurobiology of Disease.

[20]  Stephen P Bottomley,et al.  Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins. , 2009, Protein engineering, design & selection : PEDS.

[21]  R. Sabaté,et al.  Amyloids in bacterial inclusion bodies. , 2009, Trends in biochemical sciences.

[22]  R. Riek,et al.  Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218-289) are amyloids. , 2009, Angewandte Chemie.

[23]  S. Lindquist,et al.  Amyloid deposits: Protection against toxic protein species? , 2009, Cell cycle.

[24]  Kristina D. Micheva,et al.  Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.

[25]  Dalaver H. Anjum,et al.  Polyglutamine disruption of the huntingtin exon1 N-terminus triggers a complex aggregation mechanism , 2009, Nature Structural &Molecular Biology.

[26]  S. Doglia,et al.  Effects of recombinant protein misfolding and aggregation on bacterial membranes. , 2009, Biochimica et biophysica acta.

[27]  S. Doglia,et al.  In vivo aggregation of bovine beta-lactoglobulin is affected by Cys at position 121. , 2008, Protein expression and purification.

[28]  F. Avilés,et al.  Inclusion bodies: specificity in their aggregation process and amyloid-like structure. , 2008, Biochimica et biophysica acta.

[29]  A. Espargaró,et al.  Studies on bacterial inclusion bodies. , 2008, Future microbiology.

[30]  M. Chapman,et al.  Sequence determinants of bacterial amyloid formation. , 2008, Journal of molecular biology.

[31]  L. Gierasch,et al.  Orthogonal cross-seeding: an approach to explore protein aggregates in living cells. , 2008, Biochemistry.

[32]  Osamu Onodera,et al.  Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. , 2008, Human molecular genetics.

[33]  Zoya Ignatova,et al.  In-cell Aggregation of a Polyglutamine-containing Chimera Is a Multistep Process Initiated by the Flanking Sequence* , 2007, Journal of Biological Chemistry.

[34]  Stephen P Bottomley,et al.  Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. , 2007, Journal of molecular biology.

[35]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[36]  Floris Bosveld,et al.  Polarised Asymmetric Inheritance of Accumulated Protein Damage in Higher Eukaryotes , 2006, PLoS biology.

[37]  Christopher M. Dobson,et al.  Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms , 2006, The Journal of Neuroscience.

[38]  Susan Lindquist,et al.  Flanking sequences profoundly alter polyglutamine toxicity in yeast. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Stephen P Bottomley,et al.  The Two-stage Pathway of Ataxin-3 Fibrillogenesis Involves a Polyglutamine-independent Step* , 2006, Journal of Biological Chemistry.

[40]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[41]  P. Weber.  Faculty Opinions recommendation of Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent beta barrel protein. , 2006 .

[42]  Zoya Ignatova,et al.  Extended Polyglutamine Tracts Cause Aggregation and Structural Perturbation of an Adjacent β Barrel Protein* , 2006, Journal of Biological Chemistry.

[43]  Giancarlo Tonon,et al.  Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy. , 2006, Biochimica et biophysica acta.

[44]  C. Dobson.  Protein aggregation and its consequences for human disease. , 2006, Protein and peptide letters.

[45]  A. Villaverde,et al.  Amyloid-like properties of bacterial inclusion bodies. , 2005, Journal of molecular biology.

[46]  M. Saraiva,et al.  Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors. , 2005, Journal of combinatorial chemistry.

[47]  Giuseppe Nicastro,et al.  Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. , 2004, Journal of molecular biology.

[48]  Lisa D. Cabrita,et al.  Polyglutamine Expansion in Ataxin-3 Does Not Affect Protein Stability , 2004, Journal of Biological Chemistry.

[49]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[50]  P. Tortora,et al.  Temperature-dependent, irreversible formation of amyloid fibrils by a soluble human ataxin-3 carrying a moderately expanded polyglutamine stretch (Q36). , 2003, Biochemistry.

[51]  Giancarlo Tonon,et al.  FT-IR study of heterologous protein expression in recombinant Escherichia coli strains. , 2003, Biochimica et biophysica acta.

[52]  G. Bates,et al.  Huntingtin aggregation and toxicity in Huntington's disease , 2003, The Lancet.

[53]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[54]  J Dausset,et al.  Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  O. Onodera,et al.  Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation , 2001, Neuroreport.

[56]  A. Pastore,et al.  Glutamine repeats: structural hypotheses and neurodegeneration. , 2001, Biochemical Society transactions.

[57]  I. Kanazawa,et al.  Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates. , 2000, Biochemical and biophysical research communications.

[58]  N. Nukina,et al.  DMSO and glycerol reduce bacterial death induced by expression of truncated N-terminal huntingtin with expanded polyglutamine tracts. , 2000, Biochimica et biophysica acta.

[59]  J. Vance,et al.  Toxicity of expanded polyglutamine‐domain proteins in Escherichia coli , 1996, FEBS letters.

[60]  Pawel Sikorski,et al.  New model for crystalline polyglutamine assemblies and their connection with amyloid fibrils. , 2005, Biomacromolecules.

[61]  Frank Hoffmann,et al.  Stress induced by recombinant protein production in Escherichia coli. , 2004, Advances in biochemical engineering/biotechnology.

[62]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.